PietzuchM, MantelI, AmbresinA, et al.Intravitreal dexamethasone as a rescue for anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration with persistent disease activity and high treatment demand. J Ocul Pharmacol Ther, 2023 [online ahead of print]; doi: 10.1089/jop.2023.0105
2.
ColuccielloM.Letter to the Editor; in this journal.
HeloteräH, KaarnirantaK. A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration. Cells, 2022; 11(21):3453; doi: 10.3390/cells112134535
5.
MarnerosAG. Role of inflammasome activation in neovascular age-related macular degeneration. FEBS J, 2023; 290(1):28–36; doi: 10.1111/febs.16278
6.
YinX, ZhangB, ChenL, et al.Essential contribution of macrophage Tie2 signaling in a murine model of laser-induced choroidal neovascularization. Sci Rep, 2020; 10(1):9613; doi: 10.1038/s41598-020-66580-y
7.
BorchertGA, ShamsnajafabadiH, HuML, et al.The role of inflammation in age-related macular degeneration-therapeutic landscapes in geographic atrophy. Cells, 2023; 12(16):2092; doi: 10.3390/cells12162092
8.
KayaC, ZandiS, PfisterIB, et al.Adding a corticosteroid or switching to another anti-VEGF in insufficiently responsive wet age-related macular degeneration. Clin Ophthalmol, 2019; 13:2403–2409; doi: 10.2147/OPTH.S224456
9.
VerittiD, SaraoV, LanzettaP. Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors. J Ocul Pharmacol Ther, 2013; 29(4):437–441; doi: 10.1089/jop.2012.0173
10.
BecerraEM, MorescalchiF, GandolfoF, et al.Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration. Curr Drug Targets, 2011; 12(2):149–172; doi: 10.2174/138945011794182746
11.
SchaalS, KaplanHJ, TezelTH. Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration?. Ophthalmology, 2008; 115(12):2199–2205; doi: 10.1016/j.ophtha.2008.07.007
12.
Ferro DesideriL, TraversoCE, NicolòM. The emerging role of the Angiopoietin-Tie pathway as therapeutic target for treating retinal diseases. Expert Opin Ther Targets, 2022; 26(2):145–154; doi: 10.1080/14728222.2022.2036121
